{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:36:20Z","timestamp":1761708980117,"version":"3.40.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.lfs.2014.06.010","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:16:55Z","timestamp":1403569015000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Morphine glucuronidation increases its analgesic effect in guinea pigs"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3705-0581","authenticated-orcid":false,"given":"Ana","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f3nio","family":"Albino-Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.06.010_bb0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0773.1998.tb01573.x","article-title":"Differential inhibition of morphine glucuronidation in the 3- and 6-position by ranitidine in isolated hepatocytes from guinea pig","volume":"82","author":"Aasmundstad","year":"1998","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1191\/096032798678908837","article-title":"Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans","volume":"17","author":"Aasmundstad","year":"1998","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0140","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0006-2952(93)90659-K","article-title":"Different biotransformation of morphine in isolated liver cells from guinea pig and rat","volume":"46","author":"Aasmundstad","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0885-3924(01)00398-0","article-title":"Changing M3G\/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatment","volume":"23","author":"Andersen","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.lfs.2014.06.010_bb0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/00000542-200306000-00017","article-title":"Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration","volume":"98","author":"Aubrun","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.lfs.2014.06.010_bb0035","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/00000542-200406000-00032","article-title":"Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size","volume":"100","author":"Belfer","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.lfs.2014.06.010_bb0260","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/dmd.108.024190","volume":"37","author":"Buckley","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2014.06.010_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.tpj.6500095","article-title":"Molecular aspects of pain research","volume":"2","author":"Carpenter","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.lfs.2014.06.010_bb0080","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jm00108a005","article-title":"Morphine 6-glucuronide and morphine 3-glucuronide as molecular chameleons with unexpected lipophilicity","volume":"34","author":"Carrupt","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.lfs.2014.06.010_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","article-title":"Morphine metabolites","volume":"41","author":"Christrup","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.lfs.2014.06.010_bb0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1476-5381.1961.tb01101.x","article-title":"Multiple toe-pinch method for testing analgesic drugs","volume":"17","author":"Collier","year":"1961","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.lfs.2014.06.010_bb0180","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.lfs.2005.07.021","article-title":"TCDD as a biological response modifier for mitomycin C: oxygen tension affects enzyme activation, reactive oxygen species and cell death","volume":"78","author":"Collier","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2014.06.010_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-011-9274-6","article-title":"Morphine metabolism, transport and brain disposition","volume":"27","author":"De Gregori","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.lfs.2014.06.010_bb0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0890-6238(96)83995-5","article-title":"Gender differences in the mechanism of dioxin toxicity in rodents and in nonhuman primates","volume":"10","author":"Enan","year":"1996","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0890-6238(98)00017-3","article-title":"Mechanisms of gender-specific TCDD-induced toxicity in guinea pig adipose tissue","volume":"12","author":"Enan","year":"1998","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0165","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.taap.2008.02.020","article-title":"Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene","volume":"230","author":"Erichsen","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/002367784780891226","article-title":"The relief of pain in laboratory animals","volume":"18","author":"Flecknell","year":"1984","journal-title":"Lab Anim"},{"key":"10.1016\/j.lfs.2014.06.010_bb0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/62.1.166","article-title":"Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species","volume":"62","author":"Fletcher","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.lfs.2014.06.010_bb0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jpainsymman.2012.03.015","article-title":"Plasma morphine and metabolite concentrations are associated with clinical effects of morphine in cancer patients","volume":"45","author":"Gretton","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.lfs.2014.06.010_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00228-002-0490-1","article-title":"Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy","volume":"58","author":"Holthe","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-7843.2011.00814.x","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of opioids in healthy human volunteers. A minireview","volume":"110","author":"Ing Lorenzini","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/gm187","article-title":"Pharmacogenomic considerations in the opioid management of pain","volume":"2","author":"Jannetto","year":"2010","journal-title":"Genome Med"},{"key":"10.1016\/j.lfs.2014.06.010_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/17425255.4.1.77","article-title":"Role of pharmacogenetics in variable response to drugs: focus on opioids","volume":"4","author":"Kadiev","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00210-007-0205-3","article-title":"Candidate gene polymorphisms predicting individual sensitivity to opioids","volume":"377","author":"Kasai","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/med.20035","article-title":"Morphine-6-glucuronide: actions and mechanisms","volume":"25","author":"Kilpatrick","year":"2005","journal-title":"Med Res Rev"},{"key":"10.1016\/j.lfs.2014.06.010_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.forsciint.2010.07.003","article-title":"Pharmacogenetics in palliative care","volume":"203","author":"Kleine-Brueggeney","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.lfs.2014.06.010_bb0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s002280050003","article-title":"Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine","volume":"55","author":"Klepstad","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0280","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1006\/bbrc.2001.5317","article-title":"The AH receptor of the most dioxin-sensitive species, guinea pig, is highly homologous to the human AH receptor","volume":"285","author":"Korkalainen","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lfs.2014.06.010_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1248\/bpb1978.14.187","article-title":"Species difference of site-selective glucuronidation of morphine","volume":"14","author":"Kuo","year":"1991","journal-title":"J Pharmacobiodyn"},{"key":"10.1016\/j.lfs.2014.06.010_bb0290","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/0006-2952(92)90311-6","article-title":"Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions","volume":"43","author":"Lawrence","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1590\/S0100-879X2001000200013","article-title":"Endogenous opiate analgesia induced by tonic immobility in guinea pigs","volume":"34","author":"Leite-Panissi","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.lfs.2014.06.010_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pain.2006.01.010","article-title":"Current evidence for a genetic modulation of the response to analgesics","volume":"121","author":"L\u00f6tsch","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2014.06.010_bb0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/clpt.1990.145","article-title":"Oral morphine in cancer pain: influences on morphine and metabolite concentration","volume":"48","author":"McQuay","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lfs.2014.06.010_bb0170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0090-9556(24)15251-8","article-title":"Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells","volume":"27","author":"M\u00fcnzel","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2014.06.010_bb0175","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0006-2952(03)00389-7","article-title":"Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells","volume":"66","author":"M\u00fcnzel","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0065","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.2042-7158.2011.01340.x","article-title":"Pain, analgesia and genetics","volume":"63","author":"Muralidharan","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0070","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/pme.12314","article-title":"Genetic profile and cancer-related pain: a tale from two outlier cases with bone metastatic disease","volume":"15","author":"Oliveira","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.lfs.2014.06.010_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3158","article-title":"Quantification of morphine and its major metabolites M3G and M6G in antemortem and postmortem samples","author":"Oliveira","year":"2014","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.lfs.2014.06.010_bb0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/hbeh.1994.1007","article-title":"Opiate receptor blockade enhances the display of progesterone-facilitated lordosis in juvenile female guinea pigs","volume":"28","author":"Olster","year":"1994","journal-title":"Horm Behav"},{"key":"10.1016\/j.lfs.2014.06.010_bb0220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0020-711X(94)90104-X","article-title":"In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes","volume":"26","author":"Orishiki","year":"1994","journal-title":"Int J Biochem"},{"key":"10.1016\/j.lfs.2014.06.010_bb0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.1992.tb04121.x","article-title":"The analgesic activity of morphine-6-glucuronide","volume":"34","author":"Osborne","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5055\/jom.2005.0021","article-title":"Morphine analgesia in cancer pain: role of the glucuronides","volume":"1","author":"Penson","year":"2005","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.lfs.2014.06.010_bb0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/clpt.1992.42","article-title":"The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function","volume":"51","author":"Portenoy","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lfs.2014.06.010_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","article-title":"Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain","volume":"17","author":"Quigley","year":"2003","journal-title":"Palliat Med"},{"key":"10.1016\/j.lfs.2014.06.010_bb0010","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","article-title":"Clinical response to morphine in cancer patients and genetic variation in candidate genes","volume":"5","author":"Ross","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.lfs.2014.06.010_bb0160","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/taap.1998.8466","article-title":"A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects","volume":"151","author":"Santostefano","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0015","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11136-010-9738-x","article-title":"Biological pathways and genetic variables involved in pain","volume":"19","author":"Shi","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.lfs.2014.06.010_bb0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0143-4179(96)90014-1","article-title":"Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50, 488H administered intrathecally in the mouse","volume":"30","author":"Suh","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.lfs.2014.06.010_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3959(94)00148-8","article-title":"Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients","volume":"61","author":"Tiseo","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2014.06.010_bb0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0160-5402(91)90014-V","article-title":"The increasing-temperature hot-plate test: an improved test of nociception in mice and rats","volume":"25","author":"Tjolsen","year":"1991","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.lfs.2014.06.010_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2125.1994.tb04352.x","article-title":"Morphine and morphine\u2013glucuronide concentrations in plasma and CSF during long-term administration of oral morphine","volume":"38","author":"van Dongen","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0275","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14656566.9.11.1955","article-title":"Morphine-6-glucuronide: potency and safety compared with morphine","volume":"9","author":"van Dorp","year":"2008","journal-title":"Expert Opin Pharmacother"},{"year":"1996","series-title":"Cancer pain relief","author":"WHO","key":"10.1016\/j.lfs.2014.06.010_bb0005"},{"key":"10.1016\/j.lfs.2014.06.010_bb0130","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1007\/BF02854905","article-title":"Role of morphine's metabolites in analgesia: concepts and controversies","volume":"8","author":"Wittwer","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.lfs.2014.06.010_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/toxsci\/kfp115","article-title":"Introducing the \u201cTCDD-inducible AhR-Nrf2 gene battery\u201d","volume":"111","author":"Yeager","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.lfs.2014.06.010_bb0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0773.1990.tb00737.x","article-title":"Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors","volume":"66","author":"Yue","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2014.06.010_bb0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514005414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320514005414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T12:43:06Z","timestamp":1746276186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320514005414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0024320514005414"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.06.010","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphine glucuronidation increases its analgesic effect in guinea pigs","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}